Partnership Overview

ASAQ is considered the result of an innovative partnership because: multiple actors from developed and developing countries collaborated within DNDi's FACT Project to develop ASAQ with public funding sanofi-aventis, (now: Sanofi) the world's fourth-largest pharmaceutical company, agreed to produce ASAQ at cost and without patent